Kwok-Yung Yuen to Viral Envelope Proteins
This is a "connection" page, showing publications Kwok-Yung Yuen has written about Viral Envelope Proteins.
Connection Strength
1.774
-
Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol. 2013 Aug; 87(15):8638-50.
Score: 0.212
-
Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus. J Clin Virol. 2009 May; 45(1):54-60.
Score: 0.159
-
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. J Virol. 2009 Jan; 83(2):1026-35.
Score: 0.155
-
Spike protein, S, of human coronavirus HKU1: role in viral life cycle and application in antibody detection. Exp Biol Med (Maywood). 2008 Dec; 233(12):1527-36.
Score: 0.154
-
Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome. Virology. 2007 Oct 25; 367(2):428-39.
Score: 0.141
-
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Vaccine. 2005 Oct 10; 23(42):4959-68.
Score: 0.125
-
Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol. 2005 Jul; 43(7):3054-8.
Score: 0.123
-
False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J Clin Microbiol. 2004 Dec; 42(12):5885-8.
Score: 0.118
-
Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2. Emerg Microbes Infect. 2020 Dec; 9(1):1356-1359.
Score: 0.089
-
Immunization With a Novel Human Type 5 Adenovirus-Vectored Vaccine Expressing the Premembrane and Envelope Proteins of Zika Virus Provides Consistent and Sterilizing Protection in Multiple Immunocompetent and Immunocompromised Animal Models. J Infect Dis. 2018 07 02; 218(3):365-377.
Score: 0.075
-
Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination. J Virol. 2011 Nov; 85(21):11325-37.
Score: 0.047
-
An oral mucosal DNA vaccine for SARS coronavirus infections. Hong Kong Med J. 2009 Feb; 15 Suppl 2:41-2.
Score: 0.039
-
Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection. J Immunol. 2008 Jan 15; 180(2):948-56.
Score: 0.037
-
Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity. Biochem Biophys Res Commun. 2007 Jul 20; 359(1):174-9.
Score: 0.035
-
Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2006 Sep; 80(18):9279-87.
Score: 0.033
-
Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J Infect Dis. 2005 Dec 01; 192(11):1898-907.
Score: 0.031
-
Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. J Gen Virol. 2005 May; 86(Pt 5):1423-1434.
Score: 0.030
-
Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J Virol. 2005 Mar; 79(5):2678-88.
Score: 0.030
-
Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus. Antivir Ther. 2005; 10(3):393-403.
Score: 0.030
-
Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet. 2004 Mar 13; 363(9412):841-5.
Score: 0.028
-
Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein. Di Yi Jun Yi Da Xue Xue Bao. 2004 Jan; 24(1):1-6.
Score: 0.028
-
A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses. Nat Commun. 2017 07 25; 8:15672.
Score: 0.018
-
A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses. Sci Rep. 2016 Feb 25; 6:22008.
Score: 0.016
-
Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J Med Virol. 2006 Jan; 78(1):1-8.
Score: 0.008
-
[Cloning, purification, and antigenic characterization of three recombinant fragments derived from SARS-CoV S1 domain]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Sep; 19(3):275-8.
Score: 0.008
-
Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003 Oct 10; 302(5643):276-8.
Score: 0.007